The evaluation of the patient with a pancreatic mass has been outlined and suggests that, once the suspicion of a neoplasm has been raised, the major challenge is to determine the resectability of the lesion. Patients who are otherwise considered medically suitable should be offered surgery because it is the only chance for cure. In the best of circumstances, however, the five-year survival ranges from 7% to 25% after pancreaticoduodenectomy; the perioperative mortality is less than 2% and morbidity is 30% to 50% at institutions with extended experience. Although surgical resection alleviates the problems associated with biliary and/or duodenal obstruction, a pancreaticoduodenectomy should not be performed if preoperative imaging conclusively demonstrates that the disease cannot be completely resected. Although there is general agreement regarding findings that preclude resection (such as liver metastases), surgeons disagree about how much local or regional disease confers unresectability (eg, limited mesenteric venous invasion). Therefore, imaging results may have a variable impact on the decision to operate. Online shopping will cost you less – find cialis professional and enjoy the experience.
Category: Pancreatic carcinoma
Tags: Biopsy, Computed tomography, Endosonography, Pancreas adenocarcinoma, Pancreas neoplasm